Beyond Borders: Global biotechnology report 2010

Ernst & Young thought leadership
Want more? Download some of Ernst & Young’s other publications.
Progressions: Pharma 3.0
Global pharmaceutical industry report 2010
It’s a whole new ecosystem out there, one that we call Pharma 3.0. Non-traditional players are entering the mix, from
IT companies to large retailers to mobile telecommunications firms. The very business of pharma is being transformed
from producing drugs to delivering outcomes. To develop new market offerings for the Pharma 3.0 world, pharma
companies will need to team with non-traditional partners and develop new business models.
Download the report at www.ey.com/pharma
Pulse of the industry industry
Medical technology report 2009
Medtech has fared better than most industries amid the global economic downturn, but it hasn’t been entirely
immune to its effects. Long-term challenges remain, including an ongoing funding drought and a more uncertain
regulatory and reimbursement environment. Pulse of the industry reviews the industry’s performance with detailed
analysis of financial performance, financing and transaction activity in the US, European and Israeli medtech markets.
Download the report at www.ey.com/medtech
Going big: the rising influence of corporations on cleantech growth
Global cleantech insights and trends report 2009-10
Despite ongoing uncertainty about the global economic situation, cleantech spending is robust and set to accelerate,
according to Ernst & Young’s third annual global cleantech report. A survey of more than 300 top executives reveals
how the world’s largest corporations are adopting cleantech products and services to help gain competitive advantage
through resource efficiency and sustainable growth.
Download the report at www.ey.com/growth
From survival to growth
Global venture capital insights and trends report 2009
In the wake of the global economic downturn, the venture capital industry faces several difficult challenges: falling
demand for portfolio company products and services; a dearth of exit opportunities through IPOs and acquisitions;
and the need for tough decisions about the prospects of some portfolio companies. Ernst & Young’s seventh annual
report on venture capital, From survival to growth, examines the state of VC today and provides insights on topics
such as strategies for seizing opportunities in the downturn and managing working capital.
Download the report at www.ey.com/growth
108 Beyond borders Global biotechnology report 2010